tiprankstipranks

Lonnel Coats Insider Profile

4 Followers
Lonnel Coats, CEO, Director at Lexicon Pharmaceuticals, holds 1.10M shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 11.01K shares in Blueprint Medicines (Ticker: BPMC), holds ― shares in Verve Therapeutics (Ticker: VERV).
tipranks
Lonnel Coats

Lonnel Coats
Lexicon Pharmaceuticals (LXRX)
CEO, Director

Ranked #7,443 out of 97,825 Corporate Insiders

Profitable Transactions

64%
7 out of 11 Profitable Transactions

Average Return

+20.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
69.73%
30.27%
0.00%
A breakdown of Lonnel Coats's holdings

Insider Roles

Lexicon Pharmaceuticals
(LXRX)
CEO, Director
Blueprint Medicines
(BPMC)
Director
Verve Therapeutics
(VERV)
Director
Roles that Lonnel Coats holds in companies

Most Profitable Insider Trade

Stock:
Lexicon Pharmaceuticals
(LXRX)
Rating:Informative Buy
Date:Nov 13, 2023 - Today
Return:+142.90%
The most profitable trade made by Lonnel Coats

Lonnel Coats's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
Feb 29, 2024
CEO, Director
Uninformative Buy
160.79K
$2.40M
Blueprint Medicines
Jun 23, 2023
Director
Uninformative Buy
$1.04M
Verve Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Lonnel Coats's performance on stock

Lonnel Coats insider profile FAQ

What is the percentage of profitable transactions made by Lonnel Coats?
The percentage of profitable transactions made by Lonnel Coats is 64%.
    What is the average return per transaction made by Lonnel Coats?
    The average return per transaction made by Lonnel Coats is 20.90%.
      What stocks does Lonnel Coats hold?
      Lonnel Coats holds: LXRX, BPMC, VERV stocks.
        What was Lonnel Coats’s latest transaction?
        Lonnel Coats latest transaction was an Uninformative Buy of $160.79K.
          What was Lonnel Coats's most profitable transaction?
          Lonnel Coats’s most profitable transaction was an Informative Buy of LXRX stock on November 13, 2023. The return on the trade was 142.90%.
            What is Lonnel Coats's role in Lexicon Pharmaceuticals?
            Lonnel Coats's role in Lexicon Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.